Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

Conditions:   Staphylococcus Aureus Bacteremia;   Staphylococcus Aureus Endocarditis Interventions:   Drug: Exebacase;   Drug: Placebo Sponsor:   ContraFect Not yet recruiting

Source: ClinicalTrials.gov - November 13, 2019 Category: Research Source Type: clinical trials